Strongyloidiasis in Immunosuppressed Patients

Open Access
Publisher Website
Google Scholar
Abstract
An increasing number of severe, even fatal cases of strongyloidiasis in patients on immunosuppressive drugs are being reported. During a 26 month period, three severe cases of Strongyloides stercoral is infestation were diagnosed in patients who were on steroid therapy. These cases are of special interest because of the following factors. Firstly, all the patients lived in a nonendemic metropolitan area. Secondly, a single stool specimen from one patient contained several distinct developmental stages of the parasite’s life cycle. This finding appears to be unique considering the fact that the patient had not been administered a purgative or anthelminthic. Lastly, a surviving renal transplant patient continues to have persistant strongyloidiasis despite repeated Mintezol (thiabendazole) therapy.

This publication has 1 reference indexed in Scilit: